ACCP Cardiology PRN(@accpcardprn) 's Twitter Profileg
ACCP Cardiology PRN

@accpcardprn

The @ACCP Cardiology PRN advances the pharmacotherapy of CV disorders through the promotion of excellence in education, research, and clinical practice.

ID:4213804032

linkhttp://www.accp.com calendar_today12-11-2015 15:49:13

3,9K Tweets

8,9K Followers

337 Following

Follow People
ACCP Cardiology PRN(@accpcardprn) 's Twitter Profile Photo

Our next is brought to you by WakeMed's PGY-2 Cardiology Pharmacy Resident, Hannah Lunsford! Be sure to check out her infographic on DOACs in patients with a history of bariatric surgery next week! 🫀

Our next #TeachingTuesday is brought to you by WakeMed's PGY-2 Cardiology Pharmacy Resident, @hslunsford! Be sure to check out her infographic on DOACs in patients with a history of bariatric surgery next week! 🫀
account_circle
ACCP Cardiology PRN(@accpcardprn) 's Twitter Profile Photo

It's as we review the POPular-AGE trial. This showed a significant reduction in bleeding and non-inferiority for net benefit with clopidogrel compared to ticagrelor for patients >70 with NSTEMI. Graphic by Ellie Kang at Texas A&M Pharmacy

pubmed.ncbi.nlm.nih.gov/32334703/

It's #ThrowbackThursday as we review the POPular-AGE trial. This showed a significant reduction in bleeding and non-inferiority for net benefit with clopidogrel compared to ticagrelor for patients >70 with NSTEMI. Graphic by Ellie Kang at @TAMUpharmacy pubmed.ncbi.nlm.nih.gov/32334703/
account_circle
ACCP Cardiology PRN(@accpcardprn) 's Twitter Profile Photo

Check out this amazing infographic from RUSH PGY-1 Pharmacy Resident Marisol Wences going over beta blocker use with ambulatory milrinone! 🫀 Does your institution utilize this practice? 🤔

Check out this amazing infographic from @RushMedical PGY-1 Pharmacy Resident @MarisolWen16179 going over beta blocker use with ambulatory milrinone! 🫀 Does your institution utilize this practice? 🤔
account_circle
ACCP Cardiology PRN(@accpcardprn) 's Twitter Profile Photo

We are excited to highlight Vanderbilt Health 's PGY-2 Cardiology Pharmacy Resident Kennedy Manning 's CE on Anthracycline- Induced Cardiotoxicity! How does your institution monitor for this toxicity? Comment ⬇️

We are excited to highlight @VUMChealth 's PGY-2 Cardiology Pharmacy Resident @KennedyBManning 's CE on Anthracycline- Induced Cardiotoxicity! How does your institution monitor for this toxicity? Comment ⬇️
account_circle
ACCP Cardiology PRN(@accpcardprn) 's Twitter Profile Photo

It's ! Today we have the ACCOAST trial, which showed that pre-treatment with prasugrel prior to angiography doesn't reduce ischemic events but does increase the risk of bleeding. Graphic by Kennedy Manning at Vanderbilt Health

Read it here: pubmed.ncbi.nlm.nih.gov/23991622/

It's #ThrowbackThursday! Today we have the ACCOAST trial, which showed that pre-treatment with prasugrel prior to angiography doesn't reduce ischemic events but does increase the risk of bleeding. Graphic by @KennedyBManning at @VUMChealth Read it here: pubmed.ncbi.nlm.nih.gov/23991622/
account_circle
Steve Greene(@SJGreene_md) 's Twitter Profile Photo

New data from now in European Society of Cardiology Journals

Across the spectrum of patient kidney function, no significant difference in clinical or patient-reported outcomes between torsemide and furosemide for treatment of HF.

Duke Clinical Research Institute Yale Cardiology

onlinelibrary.wiley.com/doi/full/10.10…

New data from #TRANSFORM_HF now in @ESC_Journals #EJHF Across the spectrum of patient kidney function, no significant difference in clinical or patient-reported outcomes between torsemide and furosemide for treatment of HF. @DCRINews @YaleCardiology onlinelibrary.wiley.com/doi/full/10.10…
account_circle